The neovessel occlusion efficacy of 151-hydroxypurpurin-7- lactone dimethyl ester induced with photodynamic therapy

Photochemistry and Photobiology

Volumn 86, Issue 2, 2010, Pages 397-402

  Lim, Siang Hui ^a   Nowak Sliwinska, Patrycja ^b   Kamarulzaman, Fadzly Adzhar ^a   Van Den Bergh, Hubert ^b   Wagnières, Georges ^b   Lee, Hong Boon ^a  

^a CANCER RESEARCH INITIATIVES FOUNDATION   (Malaysia)

^b EPFL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAQUINONE DERIVATIVE; PHOTOSENSITIZING AGENT; PORPHYRIN; PURPURIN; VERTEPORFIN;

ANIMAL; ARTICLE; BLOOD VESSEL; CHICK EMBRYO; CHORIOALLANTOIS; DRUG EFFECT; METHODOLOGY; NEOPLASM; PHOTOCHEMOTHERAPY; RADIATION EXPOSURE; RETINA MACULA DEGENERATION; VASCULARIZATION;

ANIMALS; ANTHRAQUINONES; BLOOD VESSELS; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; MACULAR DEGENERATION; NEOPLASMS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS;

EID: 77649239493     PISSN: 00318655     EISSN: 17511097     Source Type: Journal    
DOI: 10.1111/j.1751-1097.2009.00684.x     Document Type: Article

References (29)

1. Juarranz, Á., P. Jaén, F. Sanz-Rodríguez, J. Cuevas S. González (2008) Photodynamic therapy of cancer. Basic principles and applications. Clin. Transl. Oncol. 10, 148 154.
2. Donati, G., A. D. Kapetanios C. J. Pournaras (1999) Principles of treatment of choroidal neovascularization with photodynamic therapy in age-related macular degeneration. Semin. Ophtalmol. 14, 2 10.
3. Chee, C., H. B. Lee, H. C. Ong A. S. Ho (2005) Photocytotoxic pheophorbide-related compounds from Aglaonema simplex. Chem. Biodivers. 2, 1648 1655.
4. Kim, K. K., Y. Kawano Y. Yamazaki (2003) A novel porphyrin photosensitizer from bamboo leaves that induces apoptosis in cancer cell lines. Anticancer Res. 23, 2355 2361.
5. Lange, N., J. P. Ballini, G. Wagnières H. van den Bergh (2001) A new drug-screening procedure for photosensitizing agents used in photodynamic therapy for CNV. Invest. Ophthalmol. Vis. Sci. 42, 38 46.
6. Vargas, A., M. Zeisser-Labouébe, N. Lange, R. Gurny F. Delie (2007) The chick embryo and its chorioallantoic membrane (CAM) for the in vivo evaluation of drug delivery systems. Adv. Drug Deliv. Rev. 59, 1162 1176.
7. ® studied in the chorioallantoic membrane of fertilized eggs. Photodiag. Photodyn. Ther. 2, 79 90.
8. Hammer-Wilson, M. J., D. Cao, S. Kimel M. W. Berns (2002) Photodynamic parameters in the chick chorioallantoic membrane (CAM) bioassay for photosensitizers administered intraperitoneally (IP) into the chick embryo. Photochem. Photobiol. Sci. 1, 721 728.
9. Kurohane, K., A. Tominaga, K. Sato, J. R. North, Y. Namba N. Oku (2001) Photodynamic therapy targeted to tumor-induced angiogenic vessels. Cancer Lett. 167, 49 56.
10. Ichikawa, K., Y. Takeuchi, S. Yonezawa, T. Hikita, K. Kurohane, Y. Namba N. Oku (2004) Antiangiogenic photodynamic therapy (PDT) using Visudyne causes effective suppression of tumor growth. Cancer Lett. 205, 39 48.
11. ®), in the CAM model. Angiogenesis 11, 235 243.
12. Hargus, J. A., F. R. Fronczek, M. G. Vicente K. M. Smith (2007) Mono-(L)-aspartylchlorin-e6. Photochem. Photobiol. 83, 1006 1015.
13. Fisher, H. A. Stern (1940) Die Chemie des Pyrrols Vol. 2. Akademische Verlag, Leipzig.
14. Konan, Y. N., R. Gurny E. Allémann (2002) State of the art in the delivery of photosensitizers for photodynamic therapy. J. Photochem. Photobiol. B 66, 89 106.
15. Sweetana, S. M. J. Akers (1996) Solubility principles and practices for parental drug dosage form development. PDA J. Pharm. Sci. Technol. 50, 330 342.
16. Cramers, P., M. Ruevekamp, H. Oppelaar, O. Dalesio, P. Baas F. A. Stewart (2003) FOSCAN uptake and tissue distribution in relation to photodynamic efficacy. Br. J. Cancer 88, 283 290.
17. Strickley, R. G. (2004) Solubilizing excipients in oral and injectable formulations. Pharm. Res. 21, 201 230.
18. Whitacre, C. M., D. K. Feyes, T. Satoh, J. Grossmann, J. W. Mulvihill, H. Mukhtar N. L. Oleinick (2000) Photodynamic therapy with the phthalocycnine photosensitizer Pc 4 of SW480 human colon cancer xenografts in athymic mice. Clin. Cancer Res. 6, 2021 2027.
19. Kessel, D. (2008) Determinants of photosensitization by purpurins. Photochem. Photobiol. 50, 169 174.
20. Gelderblom, H., J. Verweij, K. Nooter A. Sparreboom (2001) Cremophor EL: The drawbacks and advantages of vehicle selection for drug formulation. Eur. J. Cancer 37, 1590 1598.
21. Vargas, A., B. Pegaz, E. Debefve, Y. Konan-Kouakou, N. Lange, J.-P. Ballini, H. van den Bergh, R. Gurny F. Delia (2004) Improved photodynamic activity of porphyrin loaded into nanoparticles: An in vivo evaluation using chick embryos. Int. J. Pharm. 286, 131 145.
22. Vargas, A., M. Eid, M. Fanchaouy, R. Gurny F. Delia (2008) In vivo photodynamic activity of photosensitizer-loaded nanoparticles: formulation properties, administration parameters and biological issues involved in PDT outcome. Eur. J. Pharm. Biopharm. 69, 43 53.
23. Li, P. L. Zhao (2007) Developing early formulation: Practice and perspective. Int. J. Pharm. 341, 1 19.
24. Romanoff, A. L. (1960) The Avian Embryo. Structural and Functional Development. The Macmillan Company, New York.
25. 6 derivative (BLC1010) as photosensitizer for the closure of the neovessels. Photochem. Photobiol. 81, 1505 1510.
26. Baban, D. F. L. W. Seymour (1998) Control of tumour vascular permeability. Adv. Drug Deliv. Rev. 34, 109 119.
27. Takakura, Y., R. I. Mahato M. Hashida (1998) Extravasation of macromolecules. Adv. Drug Deliv. Rev. 34, 93 108.
28. Chowdhary, R. K., I. Shariff D. Dolphin (2003) Drug release characteristics of lipid based benzoporphyrin derivative. J. Pharm. Pharmaceut. Sci. 6, 13 19.
29. Torchilin, V. P. (2001) Structure and design of polymeric surfactant-based drug delivery systems. J. Control Release 73, 137 172.